Norelgestromin

Basic Information

Item Value
DrugBank ID DB06713
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 47

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 amenorrhea (disease) KG + DL
2 acne (disease) KG + DL
3 breast fibrocystic disease KG + DL
4 blunt duct adenosis of breast KG + DL
5 apocrine adenosis of breast KG + DL
6 benign mammary dysplasia KG + DL
7 fat necrosis of breast KG + DL
8 breast abscess KG + DL
9 lactation disease KG + DL
10 primary ovarian failure KG + DL
11 breast adenosis KG + DL
12 scalp dermatosis KG + DL
13 tetragametic chimerism KG + DL
14 ovarian remnant syndrome KG + DL
15 anovulation KG + DL
16 symptomatic form of fragile X syndrome in female carrier KG + DL
17 partial trisomy/tetrasomy of the short arm of chromosome 12 KG + DL
18 partial trisomy/tetrasomy of the short arm of chromosome 18 KG + DL
19 partial trisomy/tetrasomy of the short arm of chromosome 5 KG + DL
20 polysomy of X chromosome KG + DL
21 partial autosomal trisomy/tetrasomy KG + DL
22 luteoma of pregnancy KG + DL
23 blepharophimosis-epicanthus inversus-ptosis due to 3q23 rearrangement syndrome KG + DL
24 ovarian dysfunction KG + DL
25 ovarian ectopic pregnancy KG + DL
26 stapes ankylosis with broad thumbs and toes KG + DL
27 freemartinism KG + DL
28 blepharophimosis-epicanthus inversus-ptosis KG + DL
29 arthrogryposis epileptic seizures migrational brain disorder KG + DL
30 46,XY disorder of sex development due to impaired androgen production KG + DL
31 Leydig cell hypoplasia due to LH resistance KG + DL
32 testicular regression syndrome KG + DL
33 cryptorchidism (disease) KG + DL
34 inflammatory and autoimmune disease with epilepsy KG + DL
35 epilepsia partialis continua KG + DL
36 structural epilepsy KG + DL
37 extratemporal epilepsy KG + DL
38 post-traumatic epilepsy KG + DL
39 immune epilepsy KG + DL
40 cerebral malformation with epilepsy KG + DL
41 telecanthus KG + DL
42 penile/testicular agenesis KG + DL
43 Klinefelter syndrome KG + DL
44 ovarian hyperstimulation syndrome KG + DL
45 Kleefstra syndrome due to 9q34 microdeletion KG + DL
46 hypogonadotropic hypogonadism with or without anosmia KG + DL
47 urethral obstruction sequence KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.